James V. Caruso, President and CEO at Cellectar Biosciences, Inc. (CLRB), bought 1,000 shares at $1.30 ($1K) on 2015-11-24, disclosed to the SEC on 2015-11-25.
Open-market purchase of $1k CLRB by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CLRB | BUY | 2021-03-05 | $9K | — | Filing → |
| CLRB | BUY | 2020-12-28 | $50K | — | Filing → |
| CLRB | BUY | 2020-06-08 | $25K | — | Filing → |